HU9201254D0 - Rapamicine-carbamates and medical preparations containing them as active agents - Google Patents

Rapamicine-carbamates and medical preparations containing them as active agents

Info

Publication number
HU9201254D0
HU9201254D0 HU9201254A HU9201254A HU9201254D0 HU 9201254 D0 HU9201254 D0 HU 9201254D0 HU 9201254 A HU9201254 A HU 9201254A HU 9201254 A HU9201254 A HU 9201254A HU 9201254 D0 HU9201254 D0 HU 9201254D0
Authority
HU
Hungary
Prior art keywords
rapamicine
carbamates
active agents
preparations containing
medical preparations
Prior art date
Application number
HU9201254A
Other languages
English (en)
Hungarian (hu)
Inventor
Wenling Kao
Robert Lewis Vogel
John Henry Musser
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/686,728 external-priority patent/US5118678A/en
Priority claimed from US07/837,048 external-priority patent/US5194447A/en
Application filed by American Home Prod filed Critical American Home Prod
Publication of HU9201254D0 publication Critical patent/HU9201254D0/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
HU9201254A 1991-04-17 1992-04-13 Rapamicine-carbamates and medical preparations containing them as active agents HU9201254D0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/686,728 US5118678A (en) 1991-04-17 1991-04-17 Carbamates of rapamycin
US07/837,048 US5194447A (en) 1992-02-18 1992-02-18 Sulfonylcarbamates of rapamycin

Publications (1)

Publication Number Publication Date
HU9201254D0 true HU9201254D0 (en) 1992-07-28

Family

ID=27103855

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9201254A HU9201254D0 (en) 1991-04-17 1992-04-13 Rapamicine-carbamates and medical preparations containing them as active agents

Country Status (12)

Country Link
EP (1) EP0509795A2 (enExample)
JP (1) JPH05112573A (enExample)
KR (1) KR920019798A (enExample)
AU (1) AU642592B2 (enExample)
CZ (1) CZ117392A3 (enExample)
FI (1) FI921595A7 (enExample)
HU (1) HU9201254D0 (enExample)
IE (1) IE921249A1 (enExample)
MX (1) MX9201710A (enExample)
NO (1) NO921449L (enExample)
NZ (1) NZ242367A (enExample)
SK (1) SK117392A3 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5776943A (en) * 1991-05-14 1998-07-07 American Home Products Corporation Rapamycin metabolites
US5118677A (en) * 1991-05-20 1992-06-02 American Home Products Corporation Amide esters of rapamycin
WO1993018043A1 (en) * 1992-03-05 1993-09-16 American Home Products Corporation Novel rapamycin 42-sulfonates and 42-(n-carboalkoxy)sulfamates useful as immunosuppressive agents
GB9307491D0 (en) * 1993-04-08 1993-06-02 Sandoz Ltd Organic compounds
CH686761A5 (de) 1993-05-27 1996-06-28 Sandoz Ag Galenische Formulierungen.
EP0729471A1 (en) * 1993-11-19 1996-09-04 Abbott Laboratories Semisynthetic analogs of rapamycin (macrolides) being immunomodulators
US5527907A (en) * 1993-11-19 1996-06-18 Abbott Laboratories Macrolide immunomodulators
US5362718A (en) 1994-04-18 1994-11-08 American Home Products Corporation Rapamycin hydroxyesters
US8124630B2 (en) 1999-01-13 2012-02-28 Bayer Healthcare Llc ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
ATE538794T1 (de) 1999-01-13 2012-01-15 Bayer Healthcare Llc Gamma carboxyarylsubstituierte diphenylharnstoffverbindungen als p38 kinasehemmer
PT1210350E (pt) * 1999-08-18 2004-10-29 Wyeth Corp Esteres de sdz-rad soluveis em agua
US7838541B2 (en) 2002-02-11 2010-11-23 Bayer Healthcare, Llc Aryl ureas with angiogenesis inhibiting activity
UY28213A1 (es) 2003-02-28 2004-09-30 Bayer Pharmaceuticals Corp Nuevos derivados de cianopiridina útiles en el tratamiento de cáncer y otros trastornos.
WO2004113274A2 (en) 2003-05-20 2004-12-29 Bayer Pharmaceuticals Corporation Diaryl ureas with kinase inhibiting activity
RS52625B (sr) 2003-07-23 2013-06-28 Bayer Healthcare Llc Fluoro supstituisana omega-karboksiaril difenil urea za lečenje i prevenciju bolesti i stanja bolesti
CA2544731A1 (en) 2003-11-03 2005-05-12 Altachem Pharma Ltd. Rapamycin peptides conjugates: synthesis and uses thereof
US8021849B2 (en) 2004-11-05 2011-09-20 Siemens Healthcare Diagnostics Inc. Methods and kits for the determination of sirolimus in a sample
JP2008533007A (ja) 2005-03-07 2008-08-21 ワイス ４２−ｏ−（２−ヒドロキシ）エチル−ラパマイシンのオキセパン異性体
US7189582B2 (en) 2005-04-27 2007-03-13 Dade Behring Inc. Compositions and methods for detection of sirolimus
SG11202107653RA (en) * 2019-01-25 2021-08-30 Nodthera Ltd Carbamate derivatives and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4885171A (en) * 1978-11-03 1989-12-05 American Home Products Corporation Use of rapamycin in treatment of certain tumors
US4316885A (en) * 1980-08-25 1982-02-23 Ayerst, Mckenna And Harrison, Inc. Acyl derivatives of rapamycin
US4650803A (en) * 1985-12-06 1987-03-17 University Of Kansas Prodrugs of rapamycin
EP0487593A1 (en) * 1989-08-18 1992-06-03 FISONS plc Macrocyclic compounds
PT98990A (pt) * 1990-09-19 1992-08-31 American Home Prod Processo para a preparacao de esteres de acidos carboxilicos de rapamicina
US5118677A (en) * 1991-05-20 1992-06-02 American Home Products Corporation Amide esters of rapamycin

Also Published As

Publication number Publication date
JPH05112573A (ja) 1993-05-07
FI921595L (fi) 1992-10-18
EP0509795A2 (en) 1992-10-21
SK117392A3 (en) 1995-04-12
NZ242367A (en) 1994-07-26
FI921595A0 (fi) 1992-04-10
CZ117392A3 (en) 1993-09-15
NO921449D0 (no) 1992-04-10
IE921249A1 (en) 1992-10-21
AU1488092A (en) 1992-10-22
FI921595A7 (fi) 1992-10-18
EP0509795A3 (enExample) 1994-03-23
KR920019798A (ko) 1992-11-20
MX9201710A (es) 1993-01-01
NO921449L (no) 1992-10-19
AU642592B2 (en) 1993-10-21

Similar Documents

Publication Publication Date Title
HU9201254D0 (en) Rapamicine-carbamates and medical preparations containing them as active agents
GB8828477D0 (en) Medical aerosol formulations
HU906229D0 (en) Medical preparations
IL99291A0 (en) Cosmetic preparations
ZA897506B (en) Fungicidally active preparations
HU906721D0 (en) Methylene-diphosphonic acid derivatives and inflammation-preventing preparations containing them as active agents
EP0467218A3 (en) Combinations of active agents for skin care
GB2228200B (en) Insecticide treatment and compositions therefor
GB9125695D0 (en) Medical preparations
GB9219425D0 (en) Therapeutic agent and its use
HU00207A9 (en) Sulfonanilide derivatives and medicine
HU9201364D0 (en) Medical preparations contqining bafilomycin microlides
NZ227594A (en) Human interleukin-1alpha and preparations thereof
IL97008A0 (en) Pharmaceutical formulation containing penciclovir
HU9204072D0 (en) Terazole derivatives and medical preparatives containing them
ZA939740B (en) N-arylhydrazine derivatives as insecticidal and acaricidal agents
HU905823D0 (en) Medical preparations
GB2249788B (en) 3-amino-5-benzylidene-2-thioxo-thiazolidine-4-ones and cosmetic agents containing them
HU908294D0 (en) Fungicide preparations containing pyridyl-cyclopropane as active agent and process for the preparation of the active agents
AU1447892A (en) Pharmaceutical preparations for the therapy of tumors containing colchicine as the active principle and methods for the use of the same
HU9203050D0 (en) Thieno-cyclopentanole-oximes and pharmaceutical preparatives containing them
EP0417632A3 (en) 2-ethoxymethyl-5-hydroxy-gamma-pyrone and melanogenesis-inhibiting endermic preparation containing the same compound as active ingredient
GB9218709D0 (en) Biologically active health formulation
GB9125761D0 (en) Medical preparations
HU9202971D0 (en) Hetero-polycyclic biocidical compounds and preparatives containing them as active substance